Trending Now
Alkido Pharma Inc. (NASDAQ:AIKI) Announce Updates From Cogia BioTech Efforts To...
Alkido Pharma Inc. (NASDAQ:AIKI) and its research partner, Cogia BioTech Ltd, have delivered important updates in their efforts to expedite the study of Pancreatic...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Partners with Kenya Medical Research...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced a partnership with the Kenya Medical Research Institute (KEMRI) to plan, get regulatory authorization for, and...
MAKE IT MODERN
LATEST REVIEWS
Top Managers See 2022 as Banner Year for Oil Stocks (PXD,...
As we kick off 2022, it’s worth noting that Blackrock’s legendary investment manager, Byron Wien, once again put out his Top Ten...
MAKE IT MODERN
PERFORMANCE TRAINING
ADMA Biologics Inc (NASDAQ:ADMA) Posts A Growth Of 19% In Q2 2020 Revenues
ADMA Biologics Inc (NASDAQ:ADMA) reported an increase of 19% YoY to $7.8 million in Q2 2020. It is mainly on the backdrop of increased...
Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A. For the Development...
Exelixis Inc (NASDAQ: EXEL) has entered an exclusive license agreement with Ryvu Therapeutics S.A. focusing on the development of novel targeted therapies that employ...
NantKwest Inc. (NASDAQ:NK) and ImmunityBio Collaborate In Development of Adenovirus COVID-19 Vaccine
NantKwest Inc. (NASDAQ:NK) and ImmunityBio have entered a binding agreement term for co-development, co-manufacturer, and co-commercialization of COVID-19 vaccines and Therapeutics.
NantKwest and ImmunityBio collaborate...
Cocrystal Pharma Inc (NASDAQ: COCP)’s SARS-CoV-2 3CL Protease Lead CDI-45205 Demonstrates Vitro Activity Against...
The SARS-CoV-2 3CL protease lead CDI-45295 and several analogs of Cocrystal Pharma Inc (NASDAQ: COCP) showed potent in broad-spectrum vitro activity against the SARS-CoV-2...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Presents Positive Results Of Phase 3 TNX-102 SL...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has given an oral presentation of encouraging results from the Phase 3 clinical study, RELIEF evaluating its TNX-102...
MAKE IT MODERN
